NC-2400
/ Nippon Chemiphar
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 09, 2018
"#ImmunoOnc 2400 IO agents in development. 344 cancer vaccines, 224 cell therapies. 271 IO targets in testing by 462 entities! @endpts #BTS18 #JPM18"
(@cbtadvisors)
Biosimilar • Oncology
1 to 1
Of
1
Go to page
1